Byetta Pancreatic Cancer Allegation Attorneys: Resource4thePeople Reports Judge in Consolidated Federal Cases Sets Deadlines
| PR Web |
http://www.resource4thepeople.com/defectivedrugs/byetta.html
Resource4thePeople announced today in its latest consumer update involving lawsuits* alleging that a class of diabetes medications including Januvia, Janumet, Byetta and Victoza may cause pancreatitis, cancer and other dangerous side effects that there have been an important new development in consolidated federal litigation.
The judge overseeing the multidistrict litigation in which lawsuits from across the country over these allegations has been grouped has recently set deadlines in which lawyers for the plaintiffs must define their allegations and lawyers for the defendants must respond.
“The parties are continuing to meet and confer regarding the composition of a Master Consolidated Complaint and a Master Consolidated Answer,” said
Battaglia wrote that if there is no further impasse between the two sides the plaintiffs must file their master consolidated complaint no later than
"This order was issued after the latest status conference on
“This consolidated litigation is still in the early stages and we are informing consumers who may have been affected by these allegations that our national network of attorneys will continue to offer free consultations to those consumers who have not filed an action but wish to review their legal options to seek compensation.”
Typical of the allegations are those contained in a lawsuit *** filed by a
The
"As a result of the defective nature of Januvia, persons who were prescribed and ingested Janumet, which contains Januvia, for even a brief period of time, including Plaintiff herein, were at increased risk for developing life-threatening pancreatic cancer," she alleges in her lawsuit. "Once that cancer spreads, a patient stands just a 1.8% chance of surviving for longer than five years."
She also claims in the lawsuit that "Defendants concealed their knowledge that Janumet can cause life threatening pancreatic cancer from Plaintiff, other consumers, the general public, and the medical community. Indeed, the manufacturers of Januvia and Janumet do not even mention pancreatic cancer in their drug's respective product inserts."
The common allegations in the litigation before
“Plaintiffs in all actions allege that the use of one or more of four anti-diabetic incretin based medications – Janumet (sitagliptin combined with metformin), Januvia (sitagliptin), Byetta (exenatide) and Victoza (liraglutide) – caused them or their decedent to develop pancreatic cancer,” the panel said.
Possible links between these medications and pancreatitis and cancer were announced in a
The
These medications are known as incretin mimetic drugs and are a commonly prescribed medication for the treatment of diabetes, the
The
The
The agency said the medications are used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.
In its announcement, the
An agency official also said that a recently published study that examined insurance records also found the use of exenatide or sitagliptin could double the risk of developing acute pancreatitis.
Resource4thePeople also is recommending that consumers update themselves on media reports about the side effects, such as one posted
http://www.resource4thepeople.com/defectivedrugs/byetta.html
Sources:
*3:13-md-02452 IN RE: INCRETIN MIMETICS PRODUCTS LIABILITY LITIGATION,
**http://www.jpml.uscourts.gov/sites/jpml/files/MDL-2452-Initial_Transfer-07-13.pdf
*** Case # 3:13cv02382
****http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm344232.htm
*****http://www.bloomberg.com/news/2013-03-22/diabetes-drugs-may-cause-damage-to-pancreas-study-finds.html
Read the full story at http://www.prweb.com/releases/2013/11/prweb11370644.htm
| Copyright: | (c) 2013 PRWEB.COM Newswire |
| Wordcount: | 914 |


Amenity Health, Inc. Now Accepts FSA Debit Cards for Online Purchases of Medcline™ Reflux Relief System
Advisor News
- Survey: Most Americans still feel prosperous despite economic worries
- SEC settlement would require Tai Lopez, two others, to pay $6.8 million
- The Gen Z money paradox
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
More Advisor NewsAnnuity News
- AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on US Life/Annuity Insurance Segment
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- Boomers want retirement protection, but their actions don’t match their mindset
- NAIC task force to address LTC riders
More Annuity NewsHealth/Employee Benefits News
- EXPLORING INSULIN COST-SHARING CAPS FOR PATIENTS WITH PRIVATE COVERAGE
- THE AMERICAN DIABETES ASSOCIATION FIGHTS TO MAINTAIN ACCESS TO HEALTH INSURANCE
- Grand jury accuses veteran of making false disability claims that defrauded VA
- States push short-term insurance as healthcare costs climb
- Study Findings on Managed Care Are Outlined in Reports from Massachusetts General Hospital (A RUC Rescue of Primary Care?): Managed Care
More Health/Employee Benefits NewsLife Insurance News
- FORMER PRINCE GEORGE'S COUNTY INSURANCE AGENT SENTENCED FOR FELONY INSURANCE THEFT SCHEME
- AM Best Affirms Credit Ratings of Ameriprise Financial, Inc. and Its Subsidiaries
- AM Best Takes Various Credit Rating Actions on Certain Subsidiaries of Auto-Owners Insurance Group
- AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
- AM Best Downgrades Credit Ratings of CICA Life Insurance Company of America
More Life Insurance News